Drug Topics January 15, 2024
Rose McNulty

Patients using a predictive alarm saw a reduction of more than 40% in time spent below range in hypoglycemia and more than 60% in time spent in severe hypoglycemia.

The use of real-time continuous glucose monitoring (RT-CGM) with a predictive alarm for hypoglycemia significantly reduced the risk of hypoglycemic events among adolescents with type 1 diabetes (T1D), according to a study published in Diabetes, Obesity, and Metabolism.1

RT-CGM devices have become a widely used tool for the management of diabetes in recent years, especially in children and young people with T1D, the authors noted. They have become the standard in glycometabolic control, including among those managing diabetes with multiple daily insulin injections (MDI), and they allow for the analysis of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Provider, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article